Key Events This Week
25 May: Downgrade to Hold amid mixed technical and valuation signals
27 May: Upper circuit hit with 4.98% gain and valuation upgrade
28 May: MarketsMOJO upgrades rating to Buy on strong financials
29 May: Second upper circuit surge, closing near 52-week high

Wanbury Ltd Locks at Upper Circuit With 3.23% Gain — Buyers Queue, Sellers Absent
2026-05-29 10:00:28At Rs 315.20, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Wanbury Ltd locked at its upper circuit of 3.23% on 29 May 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Wanbury Ltd Upgraded to Buy on Strong Valuation and Financial Performance
2026-05-28 08:24:35Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy as of 27 May 2026. This change reflects significant improvements across valuation, financial trends, quality metrics, and technical indicators, signalling renewed investor confidence in the company’s growth prospects and market positioning.
Read full news article
Wanbury Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
2026-05-27 13:00:09At Rs 300.20, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Wanbury Ltd locked at its upper circuit of 5% on 27 May 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Wanbury Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Dynamics
2026-05-27 08:01:28Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change reflects evolving market perceptions amid a challenging industry backdrop, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now presenting a more compelling investment case relative to peers and historical averages.
Read full news article
Wanbury Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals
2026-05-25 08:14:59Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold following a reassessment of its valuation and technical indicators. Despite robust financial performance and strong long-term returns, concerns over valuation metrics and promoter share pledging have tempered enthusiasm among analysts.
Read full news article








